在纵向队列中,正常认知,认知障碍和痴呆症之间的过渡的预测因素
Nan Shi1, Kelly M Bakulski1, James F Burke2
1Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
Journal of Alzheimer's disease : JAD
|March 20, 2025
概括
社会人口学因素和病史影响阿尔茨海默病的进展. 非西班牙裔黑人个体表现出更快的正常认知到障碍过渡,但对痴呆症进展的障碍较慢.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
背景情况:
- 了解阿尔茨海默病和相关痴呆症 (ADRD) 的进展对于干预和预后至关重要.
- 社会人口统计学特征和病史可能会影响ADRD轨迹.
研究的目的:
- 估计正常认知,认知障碍,痴呆和死亡之间的过渡率.
- 调查这些转变与社会人口学因素/医疗史之间的关联.
主要方法:
- 多州过渡模型应用于960名参与者的纵向队列.
- 分析包括从2006年到2024年每名参与者每年进行2至16次访问.
- 估计了共变危险比率 (HRs),并根据年龄组进行了调整.
主要成果:
- 非西班牙裔黑人参与者比非西班牙裔白人参与者具有较高的正常认知到障碍率 (HR:2.29) 但较低的痴呆率 (HR:0.12).
- 赦免性损伤预测恢复正常认知的速度较慢 (HR:0.51),并且进展到痴呆的速度更快 (HR:2.51).
- 创伤性脑损伤史与认知障碍的逆转有关 (HR: 2.43).
结论:
- 影响认知障碍更快发作的因素可能会矛盾地减缓痴呆症的进展.
- 需要改进认知障碍的测量,以了解逆转和预测痴呆的发展轨迹.
- 社会人口统计学和病史变量显著影响ADRD进展和逆转动态.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.1K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.6K
相关概念视频
Cognitive Development During Adulthood
38
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
38
Dementia
81
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
81
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405
Longitudinal Research
11.8K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.8K
Longitudinal Studies
103
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
103
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
87
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
87
